CORBION NV (CRBN.AS) Fundamental Analysis & Valuation

AMS:CRBN • NL0010583399

Current stock price

18.535 EUR
+0.71 (+4.01%)
Last:

This CRBN.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CRBN.AS Profitability Analysis

1.1 Basic Checks

  • CRBN had positive earnings in the past year.
  • CRBN had a positive operating cash flow in the past year.
  • Each year in the past 5 years CRBN has been profitable.
  • Each year in the past 5 years CRBN had a positive operating cash flow.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • CRBN has a better Return On Assets (5.28%) than 72.46% of its industry peers.
  • With a decent Return On Equity value of 10.07%, CRBN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • The Return On Invested Capital of CRBN (8.13%) is better than 69.57% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.97%.
  • The last Return On Invested Capital (8.13%) for CRBN is above the 3 year average (6.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.28%
ROE 10.07%
ROIC 8.13%
ROA(3y)7.34%
ROA(5y)6.63%
ROE(3y)15.47%
ROE(5y)14.99%
ROIC(3y)6.23%
ROIC(5y)6.29%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.90%, CRBN is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CRBN has declined.
  • The Operating Margin of CRBN (9.35%) is better than 63.77% of its industry peers.
  • In the last couple of years the Operating Margin of CRBN has remained more or less at the same level.
  • CRBN's Gross Margin of 26.41% is on the low side compared to the rest of the industry. CRBN is outperformed by 60.87% of its industry peers.
  • In the last couple of years the Gross Margin of CRBN has remained more or less at the same level.
Industry RankSector Rank
OM 9.35%
PM (TTM) 5.9%
GM 26.41%
OM growth 3Y8.07%
OM growth 5Y-1.31%
PM growth 3Y-1.49%
PM growth 5Y-4.45%
GM growth 3Y5.66%
GM growth 5Y-1.14%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

6

2. CRBN.AS Health Analysis

2.1 Basic Checks

  • CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CRBN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CRBN has less shares outstanding
  • Compared to 1 year ago, CRBN has an improved debt to assets ratio.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CRBN has an Altman-Z score of 2.99. This indicates that CRBN is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.99, CRBN is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
  • The Debt to FCF ratio of CRBN is 4.82, which is a neutral value as it means it would take CRBN, 4.82 years of fcf income to pay off all of its debts.
  • CRBN has a better Debt to FCF ratio (4.82) than 69.57% of its industry peers.
  • CRBN has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • CRBN has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: CRBN outperforms 49.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.82
Altman-Z 2.99
ROIC/WACC1.35
WACC6.01%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that CRBN should not have too much problems paying its short term obligations.
  • CRBN has a Current ratio (1.89) which is in line with its industry peers.
  • A Quick Ratio of 1.11 indicates that CRBN should not have too much problems paying its short term obligations.
  • CRBN has a Quick ratio (1.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.11
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

3

3. CRBN.AS Growth Analysis

3.1 Past

  • The earnings per share for CRBN have decreased strongly by -60.82% in the last year.
  • CRBN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.67% yearly.
  • Looking at the last year, CRBN shows a decrease in Revenue. The Revenue has decreased by -1.61% in the last year.
  • The Revenue has been growing slightly by 5.14% on average over the past years.
EPS 1Y (TTM)-60.82%
EPS 3Y-5.93%
EPS 5Y0.67%
EPS Q2Q%40.21%
Revenue 1Y (TTM)-1.61%
Revenue growth 3Y-4.56%
Revenue growth 5Y5.14%
Sales Q2Q%-4.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.53% on average over the next years. This is quite good.
  • CRBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.83% yearly.
EPS Next Y6.4%
EPS Next 2Y9.61%
EPS Next 3Y10.53%
EPS Next 5YN/A
Revenue Next Year1.31%
Revenue Next 2Y2.55%
Revenue Next 3Y2.83%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. CRBN.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.59 indicates a correct valuation of CRBN.
  • Based on the Price/Earnings ratio, CRBN is valued cheaper than 82.61% of the companies in the same industry.
  • CRBN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.47.
  • The Price/Forward Earnings ratio is 12.62, which indicates a correct valuation of CRBN.
  • 84.06% of the companies in the same industry are more expensive than CRBN, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, CRBN is valued a bit cheaper.
Industry RankSector Rank
PE 14.59
Fwd PE 12.62
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 68.12% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 86.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.65
EV/EBITDA 7.05
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of CRBN may justify a higher PE ratio.
PEG (NY)2.28
PEG (5Y)21.95
EPS Next 2Y9.61%
EPS Next 3Y10.53%

6

5. CRBN.AS Dividend Analysis

5.1 Amount

  • CRBN has a Yearly Dividend Yield of 3.38%. Purely for dividend investing, there may be better candidates out there.
  • CRBN's Dividend Yield is a higher than the industry average which is at 2.18.
  • Compared to an average S&P500 Dividend Yield of 1.81, CRBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.38%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 2.76%.
Dividend Growth(5Y)2.76%
Div Incr Years0
Div Non Decr Years1
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 49.73% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
  • The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.73%
EPS Next 2Y9.61%
EPS Next 3Y10.53%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CRBN.AS Fundamentals: All Metrics, Ratios and Statistics

CORBION NV

AMS:CRBN (4/24/2026, 5:29:49 PM)

18.535

+0.71 (+4.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)07-31
Inst Owners88.79%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)1.27B
Net Income(TTM)74.80M
Analysts78.57
Price Target23.61 (27.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.38%
Yearly Dividend0.64
Dividend Growth(5Y)2.76%
DP49.73%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.11%
PT rev (3m)-1.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.58%
EPS NY rev (3m)-3.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.13%
Valuation
Industry RankSector Rank
PE 14.59
Fwd PE 12.62
P/S 0.85
P/FCF 11.65
P/OCF 6.71
P/B 1.45
P/tB 1.65
EV/EBITDA 7.05
EPS(TTM)1.27
EY6.85%
EPS(NY)1.47
Fwd EY7.92%
FCF(TTM)1.59
FCFY8.59%
OCF(TTM)2.76
OCFY14.9%
SpS21.76
BVpS12.75
TBVpS11.22
PEG (NY)2.28
PEG (5Y)21.95
Graham Number19.0863 (2.97%)
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.07%
ROCE 10.67%
ROIC 8.13%
ROICexc 8.47%
ROICexgc 9.24%
OM 9.35%
PM (TTM) 5.9%
GM 26.41%
FCFM 7.31%
ROA(3y)7.34%
ROA(5y)6.63%
ROE(3y)15.47%
ROE(5y)14.99%
ROIC(3y)6.23%
ROIC(5y)6.29%
ROICexc(3y)6.54%
ROICexc(5y)6.74%
ROICexgc(3y)7.3%
ROICexgc(5y)7.76%
ROCE(3y)8.19%
ROCE(5y)8.26%
ROICexgc growth 3Y-2.19%
ROICexgc growth 5Y-6.77%
ROICexc growth 3Y0.85%
ROICexc growth 5Y-3.6%
OM growth 3Y8.07%
OM growth 5Y-1.31%
PM growth 3Y-1.49%
PM growth 5Y-4.45%
GM growth 3Y5.66%
GM growth 5Y-1.14%
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.82
Debt/EBITDA 1.7
Cap/Depr 79.49%
Cap/Sales 5.38%
Interest Coverage 7.69
Cash Conversion 78.76%
Profit Quality 123.93%
Current Ratio 1.89
Quick Ratio 1.11
Altman-Z 2.99
F-Score7
WACC6.01%
ROIC/WACC1.35
Cap/Depr(3y)117.66%
Cap/Depr(5y)178.72%
Cap/Sales(3y)7.91%
Cap/Sales(5y)10.76%
Profit Quality(3y)66%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.82%
EPS 3Y-5.93%
EPS 5Y0.67%
EPS Q2Q%40.21%
EPS Next Y6.4%
EPS Next 2Y9.61%
EPS Next 3Y10.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.61%
Revenue growth 3Y-4.56%
Revenue growth 5Y5.14%
Sales Q2Q%-4.49%
Revenue Next Year1.31%
Revenue Next 2Y2.55%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y30.65%
EBIT growth 3Y3.14%
EBIT growth 5Y3.77%
EBIT Next Year79.02%
EBIT Next 3Y26.5%
EBIT Next 5YN/A
FCF growth 1Y-7.21%
FCF growth 3YN/A
FCF growth 5Y35.76%
OCF growth 1Y-12.6%
OCF growth 3Y60.39%
OCF growth 5Y8.1%

CORBION NV / CRBN.AS Fundamental Analysis FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status for CRBN stock?

ChartMill assigns a valuation rating of 6 / 10 to CORBION NV (CRBN.AS). This can be considered as Fairly Valued.


How profitable is CORBION NV (CRBN.AS) stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CORBION NV (CRBN.AS) stock?

The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 14.59 and the Price/Book (PB) ratio is 1.45.


How financially healthy is CORBION NV?

The financial health rating of CORBION NV (CRBN.AS) is 6 / 10.